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Concise statement: A growing body of evidence challenges the assertion that adolescence 
represents a period of vulnerability to neurocognitive harms of cannabis use. Innovative and cross-
discipline methodologies are required to address limitations and work towards reliable public health 
messages. 
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Reporting in Addiction (1) on data from the Environmental Risk Longitudinal Twin Study (E-Risk), 
Meier et al. found no evidence that adolescent cannabis use or dependence was associated with IQ 
decline between the ages of 12 and 18 years. Moreover, they found no difference in age 18 IQ 
between co-twins discordant for cannabis use and minimal differences in executive functioning, 
suggesting family background factors may explain lower neurocognitive performance often reported 
in cannabis users. The authors therefore conclude, “…relatively short-term cannabis use in 
adolescence does not appear to cause IQ decline or impair executive functions, even when cannabis 
use reaches the level of dependence.”  
As Meier at al. discuss, these findings are in line with a number of recent prospective cohort studies 
on cannabis use and neurocognitive performance, in which outcomes were assessed during 
adolescence or early adulthood (2-5). Of interest, Meier et al. draw a comparison between these 
studies and two other cohorts with follow-ups in older adulthood that instead did find evidence of 
neurocognitive decline in cannabis users (6, 7). Without longer follow-up, whether impairment will 
emerge in later life in the younger cannabis users is not clear. However, given the common 
assumption that cannabis use in adolescence is particularly detrimental to neurocognitive 
functioning, relative to delaying use until adulthood, the lack of impairment in young cannabis users 
is of interest. 
Assertions that adolescence represents a period of vulnerability to neurocognitive harms of cannabis 
use are largely based on a previous, highly influential study by Meier and colleagues using the 
Dunedin cohort (6). Here they reported that adolescent- but not adult-onset cannabis users 
experienced IQ decline, but only in those who had persistent, heavy cannabis use or dependence 
during adulthood. Some (8-13), though certainly not all (14-17), smaller cross-sectional studies have 
also found evidence of lower performance in early- compared to late-onset or non-users, or of 
associations between age of onset and performance. There is however very little consistency across 
studies, particularly in terms of affected cognitive domains.  
An important consideration, as highlighted by Meier et al. (1), is that only 1% of the E-Risk cohort 
used cannabis multiple times a day. Could this very heavy level of use cause neurocognitive decline 
in adolescence, which was not detected in the E-Risk cohort? In order to test this, Meier et al. point 
out that larger cohort studies will be needed, such as the recently initiated Adolescent Brain 
Cognitive Development study (n=10,000) (18). However, since very heavy use is rare in the general 
population, even large cohorts may not be adequately powered to test such effects.  
One way to address this issue is to recruit according to pre-specified cannabis use levels, ensuring 
that heavy-users are over-sampled. Such a design, implemented longitudinally, could increase 
statistical power to assess neurocognitive trajectories associated with long-term heavy cannabis use 
in adolescence and beyond. Importantly, comparisons between early- and late-onset users are often 
substantially confounded by longer duration and heavier cannabis use (e.g. three times the quantity 
and twice as often (11)) in early-onset users. To better address the question of adolescent 
vulnerability, innovative methods of matching participants (e.g. propensity score matching) of 
different ages and ages of onset on key cannabis use variables and other factors, could reduce 
(though never completely eliminate) this potential confounding.  
Placebo-controlled studies can also complement observational methods, allowing assessment of 
causal effects of cannabis exposure in different age groups. Indeed, we recently showed contrasting 
patterns of acute cannabis effects in adolescent and adult cannabis users (19). Specifically, 
adolescents experienced blunted intoxication and memory effects of cannabis, offering preliminary 
evidence that adolescents may be resilient to some acute effects of cannabis. As cannabis policy 
changes, randomised controlled trials testing effects of repeated administration of medicinal 
cannabis products on neurocognitive functioning in certain populations may also become feasible. 
In conclusion, this paper adds to a growing body of evidence challenging the assertion that 
adolescence is a period of vulnerability to putative neurocognitive harms of cannabis use.  It is 
important that, while the evidence remains unclear, the risks to teenagers using cannabis, parents, 
and policy-makers alike are not over-stated. Further research using innovative and complementary 
methods will be key in advancing our understanding of age-related differences in vulnerability.  
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